Jefferies Upgrades Magellan, Says 'Path To 20% EPS Growth Improving'

By: via Benzinga
In a report published Wednesday, analysts at Jefferies upgraded Magellan Health Inc (NASDAQ: MGLN) from Buy to Hold. The price target ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.